Skip to main content
Stephen Sherwin, MD, Oncology, San Francisco, CA

StephenAlanSherwinMD

Oncology San Francisco, CA

Physician

Are you Dr. Sherwin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 45 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    995 Potrero Ave
    Bldg 80
    San Francisco, CA 94110
    Phone+1 415-476-4082

Summary

  • Dr. Stephen Sherwin, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California, Maryland, and New York. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
  • Harvard Medical School
    Harvard Medical SchoolClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1975 - Present
  • CA State Medical License
    CA State Medical License 1980 - 2025
  • MD State Medical License
    MD State Medical License 1976 - 1991
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • NEUVOGEN Appoints Stephen a. Sherwin, M.D. To Its Scientific Advisory Board
    NEUVOGEN Appoints Stephen a. Sherwin, M.D. To Its Scientific Advisory BoardJuly 25th, 2022
  • Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board
    Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory BoardJanuary 26th, 2017
  • Third Rock Ventures Closes Fund IV at $616M
    Third Rock Ventures Closes Fund IV at $616MNovember 3rd, 2016
  • Join now to see all